(Q34320187)

1 August 2017

1 reference

title

Current status and perspectives of therapy for acute myeloid leukemia (English)

1 reference

1 August 2017

1 reference

Hiddemann W

1

1 reference

1 August 2017

Büchner T

series ordinal

2

1 reference

1 August 2017

publication date

1 July 2001

1 reference

1 August 2017

published in

Seminars in Hematology

1 reference

1 August 2017

volume

38

1 reference

1 August 2017

issue

3 Suppl 6

1 reference

1 August 2017

page(s)

3-9

1 reference

1 August 2017

cites work

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990150-7

7 January 2021

Tailoring the treatment of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990150-7

7 January 2021

Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy: relevance of cytogenetic abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990150-7

7 January 2021

The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990150-7

7 January 2021

Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organiz

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990150-7

7 January 2021

Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990150-7

7 January 2021

Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990150-7

7 January 2021

Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16).

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990150-7

7 January 2021

Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990150-7

7 January 2021

Management of acute myeloid leukemia in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990150-7

7 January 2021

Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990150-7

7 January 2021

Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990150-7

7 January 2021

10.1016/S0037-1963(01)90150-7

Identifiers

DOI

1 reference

1 August 2017

1 reference